Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Bulletin Du Cancer|December 18, 2021
[Bispecific antibodies in multiple myeloma]Guillaume Escure, Salomon ManierBlood Reviews|February 8, 2022
Current state and next-generation CAR-T cells in multiple myelomaSalomon Manier, Tiziano Ingegnere, Guillaume Escure, et al.Frontiers in Oncology|January 29, 2019
Deregulation and Targeting of TP53 Pathway in Multiple MyelomaKatarina K Jovanović, Guillaume Escure, Jordane Demonchy, et al.International Journal of Antimicrobial Agents|March 5, 2019
Discontinuation of antimicrobial therapy in adult neutropenic haematology patients: A prospective cohortZoé Van de Wyngaert, Céline Berthon, Houria Debarri, et al.Haematologica|May 15, 2025
Clinical benefit of tafasitamab plus lenalidomide in relapsed or refractory diffuse large Bcell lymphoma: real-world data from the EarlyMIND studyGabriel Brisou, Jérôme Paillassa, Sophie Bernard, et al.Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 3, 2024
Characteristics and incidence of infections in patients with multiple myeloma treated by bispecific antibodies: a national retrospective studyAurélie Jourdes, Elise Cellerin, Cyrille Touzeau, et al.Blood Advances|March 21, 2024
Genomic profiling of mycosis fungoides identifies patients at high risk of disease progressionLéa Fléchon, Inès Arib, Ankit K Dutta, et al.Pageof 1